OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin with Leptin Receptor Agonist REGN4461

Background: An 18-year-old patient with atypical partial lipodystrophy had a transient initial metabolic response to metreleptin that deteriorated when neutralizing antibodies against metreleptin developed. A therapeutic trial with setmelanotide did not result in any metabolic benefit as desired. Be...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Endocr Soc
Main Authors: Akinci, Baris, de Freitas, Maria Cristina Foss, Baker, Mark, Hench, Rita, Neidert, Adam, Boutros, Sabine, Akinci, Efe Yagiz, Oral, Elif A
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Adipose Tissue, Appetite, and Obesity
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207664/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1072
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki